GeoWealth Management’s iShares Core MSCI International Developed Markets ETF IDEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-7,857
Closed -$699K – 979
2026
Q2
$699K Sell
7,857
-14
-0.2% -$1.24K 0.02% 415
2026
Q1
$658K Sell
7,871
-988
-11% -$85K 0.02% 408
2025
Q4
$731K Sell
8,859
-2,443
-22% -$199K 0.03% 354
2025
Q3
$906K Sell
11,302
-400
-3% -$31.1K 0.03% 322
2025
Q2
$890K Sell
11,702
-785
-6% -$56.7K 0.03% 284
2025
Q1
$860K Buy
12,487
+809
+7% +$55.2K 0.03% 304
2024
Q4
$753K Sell
11,678
-4,214
-27% -$284K 0.02% 375
2024
Q3
$1.13M Sell
15,892
-1,603
-9% -$109K 0.04% 277
2024
Q2
$1.15M Buy
17,495
+471
+3% +$31.3K 0.05% 239
2024
Q1
$1.14M Sell
17,024
-339
-2% -$21.8K 0.04% 267
2023
Q4
$1.1M Sell
17,363
-680
-4% -$40.5K 0.09% 201
2023
Q3
$1.05M Buy
+18,043
New +$1.09M 0.12% 143

Other funds holding IDEV

GeoWealth Management's IDEV Position: Q3 2026 in Review

GeoWealth Management sold out of iShares Core MSCI International Developed Markets ETF (IDEV) in Q3 2026, closing a stake of 7,857 shares — an estimated $699K sold.

GeoWealth Management first reported a position in IDEV in Q3 2023 and held it in 12 quarters. The position peaked at $1.15M in Q2 2024. 800 funds tracked by Wall St. Rank hold IDEV as of Q3 2026.

  • GeoWealth Management reported no remaining iShares Core MSCI International Developed Markets ETF position as of Q3 2026 after selling out during the quarter.
  • GeoWealth Management sold 7,857 iShares Core MSCI International Developed Markets ETF shares in Q3 2026, an estimated $699K.
  • GeoWealth Management first reported a position in iShares Core MSCI International Developed Markets ETF in Q3 2023 and held it in 12 quarters.
  • GeoWealth Management's iShares Core MSCI International Developed Markets ETF position peaked at $1.15M in Q2 2024.
  • 800 funds tracked by Wall St. Rank held iShares Core MSCI International Developed Markets ETF as of Q3 2026.

Based on GeoWealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.